Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer is a research paper published in Clinical and Translational Discovery (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA269211
National Institutes of Health
Grant: R01 CA266510
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords